These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 21111938

  • 1. Kidney graft outcomes in living-related transplantation have improved with substitution of basiliximab and mycophenolate mofetil for antithymocyte globulin and azathioprine: a single center retrospective cohort study.
    Imamović G, Zerem E, Osmanović E.
    Eur J Intern Med; 2010 Dec; 21(6):524-9. PubMed ID: 21111938
    [Abstract] [Full Text] [Related]

  • 2. Comparison of sequential protocol using basiliximab versus antithymocyte globulin with high-dose mycophenolate mofetil in recipients of a kidney graft from an expanded-criteria donor.
    Pallet N, Anglicheau D, Martinez F, Mamzer MF, Legendre C, Thervet E.
    Transplantation; 2006 Mar 27; 81(6):949-52. PubMed ID: 16570022
    [Abstract] [Full Text] [Related]

  • 3. Differential influence of azathioprine and mycophenolate mofetil on the disposition of basiliximab in renal transplant patients.
    Kovarik JM, Pescovitz MD, Sollinger HW, Kaplan B, Legendre C, Salmela K, Book BK, Gerbeau C, Girault D, Somberg K, Simulect Phase IV Sudy group.
    Clin Transplant; 2001 Apr 27; 15(2):123-30. PubMed ID: 11264639
    [Abstract] [Full Text] [Related]

  • 4. Basiliximab versus rabbit antithymocyte globulin as induction therapy for living-related renal transplantation: a single-center experience.
    Huang HF, Zhou JY, Xie WQ, Wu JY, Deng H, Chen JH.
    Int Urol Nephrol; 2016 Aug 27; 48(8):1363-1370. PubMed ID: 27170340
    [Abstract] [Full Text] [Related]

  • 5. A Prospective Randomized, Comparative Trial of High-Dose Mizoribine Versus Mycophenolate Mofetil in Combination With Tacrolimus and Basiliximab for Living Donor Renal Transplant: A Multicenter Trial.
    Ishida H, Takahara S, Amada N, Tomikawa S, Chikaraishi T, Takahashi K, Uchida K, Akiyama T, Tanabe K, Toma H, Study Group for the Antimetabolite Comparison of Trial (AMCT).
    Exp Clin Transplant; 2016 Oct 27; 14(5):518-525. PubMed ID: 27733107
    [Abstract] [Full Text] [Related]

  • 6. Rabbit antithymocyte globulin versus basiliximab in renal transplantation.
    Brennan DC, Daller JA, Lake KD, Cibrik D, Del Castillo D, Thymoglobulin Induction Study Group.
    N Engl J Med; 2006 Nov 09; 355(19):1967-77. PubMed ID: 17093248
    [Abstract] [Full Text] [Related]

  • 7. Comparison of single bolus ATG and Basiliximab as induction therapy in presensitized renal allograft recipients receiving tacrolimus-based immunosuppressive regimen.
    Yang SL, Wang D, Wu WZ, Lin WH, Xu TZ, Cai JQ, Tan JM.
    Transpl Immunol; 2008 Jan 09; 18(3):281-5. PubMed ID: 18047938
    [Abstract] [Full Text] [Related]

  • 8. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.
    Transpl Immunol; 2008 Nov 09; 20(1-2):32-42. PubMed ID: 18773960
    [Abstract] [Full Text] [Related]

  • 9. Calcineurin-inhibitor avoidance in elderly renal allograft recipients using ATG and basiliximab combined with mycophenolate mofetil.
    Guba M, Rentsch M, Wimmer CD, Uemueksuez A, Illner WD, Schönermarck U, Land WG, Jauch KW, Arbogast H.
    Transpl Int; 2008 Jul 09; 21(7):637-45. PubMed ID: 18282242
    [Abstract] [Full Text] [Related]

  • 10. Basiliximab and mycophenolate mofetil in combination with low-dose cyclosporine and methylprednisolone effectively prevent acute rejection in kidney transplant recipients.
    Kovac D, Kotnik V, Kandus A.
    Transplant Proc; 2005 Dec 09; 37(10):4230-4. PubMed ID: 16387086
    [Abstract] [Full Text] [Related]

  • 11. Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients.
    Oberholzer J, John E, Lumpaopong A, Testa G, Sankary HN, Briars L, Kraft KA, Knight PS, Verghese P, Benedetti E.
    Pediatr Transplant; 2005 Aug 09; 9(4):456-63. PubMed ID: 16048597
    [Abstract] [Full Text] [Related]

  • 12. Rescue immunosuppressive therapies in living-related renal allotransplant: a long-term prospective randomized evaluation.
    Bakr MA, Gheith OA, Ismael AM, Baz ME, Shehab El-Dein AB, Ghoneim MA.
    Exp Clin Transplant; 2008 Mar 09; 6(1):48-53. PubMed ID: 18405245
    [Abstract] [Full Text] [Related]

  • 13. Superior Patient and Graft Survival in Adult Liver Transplant with Rabbit Antithymocyte Globulin Induction: Experience with 595 Patients.
    Montenovo MI, Jalikis FG, Li M, Yeh M, Dick A, Hansen R, Reyes JD.
    Exp Clin Transplant; 2017 Aug 09; 15(4):425-431. PubMed ID: 27309029
    [Abstract] [Full Text] [Related]

  • 14. Induction treatment with rabbit antithymocyte globulin versus basiliximab in renal transplant recipients with planned early steroid withdrawal.
    Martin ST, Roberts KL, Malek SK, Tullius SG, Vadivel N, De Serres S, Grafals M, Elsanjak A, Filkins BA, Chandraker A, Gabardi S.
    Pharmacotherapy; 2011 Jun 09; 31(6):566-73. PubMed ID: 21923440
    [Abstract] [Full Text] [Related]

  • 15. Basiliximab induction in renal transplantation: long-term outcome.
    Atlani M, Sharma RK, Gupta A.
    Saudi J Kidney Dis Transpl; 2013 May 09; 24(3):473-9. PubMed ID: 23640617
    [Abstract] [Full Text] [Related]

  • 16. Rabbit antithymocyte globulin compared with basiliximab in kidney transplantation: a single-center study.
    Kim JM, Jang HR, Kwon CH, Huh WS, Kim GS, Kim SJ, Joh JW, Oh HY.
    Transplant Proc; 2012 Jan 09; 44(1):167-70. PubMed ID: 22310606
    [Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of induction treatment with low thymoglobulin doses in kidney transplantation from expanded-criteria donors.
    Sancho Calabuig A, Gavela Martínez E, Kanter Berga J, Beltrán Calatán S, Avila Bernabeu AI, Pallardó Mateu LM.
    Transplant Proc; 2015 Jan 09; 47(1):50-3. PubMed ID: 25645768
    [Abstract] [Full Text] [Related]

  • 18. Outcomes of Early Steroid Withdrawal in Recipients of Deceased-Donor Expanded Criteria Kidney Transplants in the Era of Induction Therapy.
    Hussain SM, Marcus RJ, Ko TY, Nashar K, Thai NL, Sureshkumar KK.
    Exp Clin Transplant; 2016 Jun 09; 14(3):287-93. PubMed ID: 27221720
    [Abstract] [Full Text] [Related]

  • 19. Meta-analysis of basiliximab for immunoprophylaxis in renal transplantation.
    Keown P, Balshaw R, Khorasheh S, Chong M, Marra C, Kalo Z, Korn A.
    BioDrugs; 2003 Jun 09; 17(4):271-9. PubMed ID: 12899644
    [Abstract] [Full Text] [Related]

  • 20. Long-term graft outcome with mycophenolate mofetil and azathioprine: A paired kidney analysis.
    Shah S, Collett D, Johnson R, Thuraisingham RC, Raftery MJ, Rudge CJ, Yaqoob MM.
    Transplantation; 2006 Dec 27; 82(12):1634-9. PubMed ID: 17198250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.